ABSTRACT

In healthcare, it is rare to achieve consensus across all stakeholder groups. However,on the matter of ‘compliance with treatment’, there is universal agreement across themedical profession, government, industry and, most importantly, patients: compliance rates must be addressed to achieve optimum health benefits, most appropriate use of limited healthcare resources and cost benefits for each nation’s healthcare budget.

It is this consensus that perhaps offers the greatest opportunity to improve compliance rates. In isolation, each of the stakeholders has made little impact. However, in recent years, we have started to see some cooperative initiatives that have provided some positive signs for the future. While there remains much work to be done, with all stakeholders benefiting from the improved taking of medicines, there is good cause for optimism that government, medical professionals and industry can work in collaboration for the benefit of patients.